| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 05/31/2006 | EP1446122B1 Use of flibanserin in the treatment of sexual desire disorders |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060110470 Pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/17/2006 | EP1656183A1 Treatment of male sexual dysfunction |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/16/2006 | US7045543 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders |
| 05/11/2006 | US20060099255 solid dosage forms for oral administration, reducing the range in daily dosages required to control pain in human patients |
| 05/10/2006 | EP1653968A2 Method for modulating calcium ion-release-activated calcium ion channels |
| 05/10/2006 | EP1450834B9 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 05/04/2006 | US20060095003 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 05/04/2006 | US20060094783 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060093626 Lyophilization; conjugated Streptococcus pneumoniae capsular polysaccharide serotype is adjuvanted with 3-0 deacylated monophosphoryl lipid A (3D-MPL) and devoid of aluminium-based adjuvant |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1490049B1 Citalopram for the treatment of elevated blood pressure |
| 05/03/2006 | EP1425005B1 Pharmaceutical compostion comprising lumiracoxib |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | CN1767835A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/03/2006 | CN1765899A Diazabicyclic central nervous system active agents |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 04/26/2006 | EP1648362A2 Film comprising therapeutic agents |
| 04/26/2006 | EP1408953B1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/26/2006 | CN1762494A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 04/26/2006 | CN1253205C 疫苗 Vaccine |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250226C Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tboc amino-phenyl)ethoxy]phenyl}-(S)-2-ethoxy propionic ac |
| 04/12/2006 | CN1250215C Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022108 Method for delivery of therapeutic and/or diagnostic agents |
| 03/30/2006 | US20060069075 Methods for treating dry eye |
| 03/29/2006 | EP1347765B1 Dermatological aqueous formulations containing clindamycin and a water soluble zinc salt |
| 03/29/2006 | CN1753673A Prodrugs of gaba analogs, compositions and uses thereof |
| 03/28/2006 | CA2290963C S-omeprazole magnesium trihydrate |
| 03/23/2006 | US20060062860 Use of anemonin for treating aseptic inflammations |
| 03/22/2006 | EP1636236A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 03/22/2006 | EP1636233A1 Cannabinoid receptor ligands and uses thereof |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1245958C Controlled release hydroxy-ketone |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/16/2006 | US20060058381 Pharmaceutical formulation comprising (r)-bicalitamide |
| 03/16/2006 | US20060057210 for oral administration, reducing the range in daily dosages required to control pain in human patients; specified mean maximum plasma concentration |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/09/2006 | US20060051361 Vaccine against Streptococcus pneumoniae |
| 03/08/2006 | EP1631306A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 03/08/2006 | EP1631145A2 P38 kinase inhibitor compositions and methods of using the same |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | CN1744902A Pharmaceutical combination for the treatment of cancer |
| 03/08/2006 | CN1743331A Process for preparing azacycloalkanoylaminothiazoles |
| 03/02/2006 | US20060046979 Organic compounds |
| 03/01/2006 | EP1379203B1 Condom with an erectogenic composition |
| 03/01/2006 | EP1345942B1 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 02/28/2006 | CA2382426C Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | US20060040969 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/15/2006 | EP1624935A2 Anti-adhesion composites and methods os use thereof |
| 02/15/2006 | CN1733727A Crystalline carvedilol, processes for the manufacture thereof, pharmaceutical compositions and uses thereof |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/08/2006 | EP1622684A2 Compositions and methods relating to novel compounds and targets thereof |
| 02/08/2006 | EP1622663A2 Apparatus and method for delivery of therapeutic and/or diagnostic agents |
| 02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 02/07/2006 | US6995167 Arylkylamine spirofuropyridines useful in therapy |
| 02/02/2006 | US20060025590 Novel compounds |
| 02/01/2006 | EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1728993A Pharmaceutical composition comprising lumiracoxib |
| 01/31/2006 | US6992104 C7 carbonate taxane compositions |
| 01/31/2006 | US6991620 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 01/31/2006 | US6991619 Apparatus for delivery of therapeutic and/or diagnostic agents |